Update on Stroke Risks
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Parkinson Disease: Functional Assessment, Gene Disruptions, and More
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Anti-epileptics in Pregnancy?
What are the risks of anti-seizure meds in pregnancy? Benefits?
What’s in a Name? The Seizure Classification Update and What It All Means
The conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.
The Neglected Diagnosis: Mood Disorders in Patients With Epilepsy
Which came first? Epilepsy or depression? The author sheds light on a complex relationship.
Caloric Vestibular Stimulation Device Prevented Episodic Migraine
This study showed that a novel CVS device provided effective, well-tolerated adjuvant prophylactic therapy for a group of adults with episodic migraine.
Do Dairy Products Increase Risk of Parkinson Disease?
The largest study to date of a potential link between dairy intake and Parkinson disease found that risk varies depending on fat content and total intake. Details here.
Emerging Strategies for Migraine Therapy
Here’s a quick overview of what’s new—and what may be coming—in preventive treatments strategies for migraine.
Controversy Continues Regarding PPI Use and Dementia
A dementia expert addresses current controversies on proton pump inhibitors.
How Safe is Long-term Antiplatelet Rx After a Vascular Event?
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.